Actinobacillus actinomycetemcomitans is considered to be associated with various forms of human periodontal disease (18) . The microorganism has a variety of cell surface components such as fimbriae, serotype-specific polysaccharide antigen, and lipopolysaccharide (1, 13, 19) . These cell surface components may play important roles in colonization and pathogenicity. Antifimbrial antibodies are considered to inhibit the colonization of many bacterial species (14) , and fimbriae of periodontopathic bacteria such as Porphyromonas gingivalis (6) and A. actinomycetemcomitans may constitute good candidates for vaccines to prevent these colonizations.
The sum of the attractive and repulsive forces between a multivalent antibody and multivalent antigen is termed the functional avidity (17) . Protective efficacy against infection is thought to be a function of such antibody avidity (10) . The purpose of the present study was to gain information about the relative avidity of serum immunoglobulin G (IgG) antibody elicited against fimbria antigen of A. actinomycetemcomitans. Forty-two patients (mean age, 45 years; age range, 22 to 66 years) with clinical diagnoses of adult periodontitis were selected for this study. Patients who met the clinical selection criteria but had used antibiotics in the previous 6 months, suffered from systemic diseases, or refused to participate in the study were excluded. Blood samples were collected from each subject by venipuncture. Serum from clotted venous blood was harvested by centrifugation and stored at -70°C. Serum samples from 10 subjects ranging in age from 24 to 29 years, who were judged to be periodontally healthy by clinical examination, were also obtained. Subgingival plaque samples were obtained from at least two sites by using paper points, with the deepest probing depth per individual. The samples were transferred to 1 ml of reduced transport fluid (16) and dispersed in a Vortex mixer for 15 s at the maximum setting. The sample was serially diluted 10-fold for culture study. An aliquot of 0.1 ml was plated on TSBV medium (15) 10 ,000 x g for 20 min and then at 25,000 x g for 30 min. A saturated solution of (NH4)2SO4 was added dropwise to the supernatant until a final concentration of 10% was reached. The precipitate (crude fimbriae) was purified to near homogeneity by being dissolved in 0.5% deoxycholate-0.7% n-octyl-,B-D-glucopyranoside. These detergents selectively dissolved 30-and < 18-kDa proteins. The purified fimbriae were negatively stained with 0.2% sodium phosphotungstic acid (NaPT [pH 7]) by the method of Preus et al. (11) and subjected to electron-microscopic examination (H-600; Hitachi, Tokyo, Japan). Extracted fimbriae were seen to be composed only of fibrous components similar to the fimbriae isolated by Inoue et al. (4) . Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis of this material clearly showed a band at 54 kDa. This 54-kDa antigen corresponds to the fimbrial subunit protein reported by Inoue et al. (4) .
Serum IgG titers against the purified antigen were assessed by an enzyme-linked immunosorbent assay (ELISA) with peroxidase-conjugated goat anti-human IgG as described by Nakagawa et al. (9) . The antibody levels were expressed as ELISA units by the method of Murayama et al. (8) . The treatment of serum with a mild protein denaturant, comitans culture-positive patients with elevated levels of serum antibodies against the fimbria antigen was 50% (12 of 24 patients), whereas that of A. actinomycetemcomitans culture-negative patients was 33% (6 of 18 patients). Avidities of sera with elevated antibody levels were compared in terms of the presence of cultivable A. actinomycetemcomitans. Sera from A. actinomycetemcomitans culture-negative patients with elevated IgG titers against the fimbria antigen had significantly (P < 0.01) higher avidities for the fimbria antigen than did sera from A. actinomycetemcomitans culture-positive patients with elevated titers (Al, 76.2 + 10.2 and 45.2 + 6.3, respectively). The relationships between titers and avidities between the groups were assessed by Spearman's rank correlation coefficient. A statistically significant negative correlation was noted between titers and avidities for the fimbria antigen in periodontally normal individuals (r, = -0.888; P < 0.05) and patients with cultivable A. actinomycetemcomitans (rs = -0.436; P < 0.05). For patients without cultivable A. actinomycetemcomitans, however, a significantly positive correlation (rS = 0.612; P < 0.05) existed between titers and avidities for the fimbria antigen.
Ranney et al. (12) and Gunsolley et al. (3) showed that the severity of lesions of localized juvenile periodontitis or severe periodontitis in patients with high antibody levels against A. actinomycetemcomitans is limited compared with that of patients with low antibody titers, thus emphasizing the protective role of anti-A. actinomycetemcomitans antibody. In contrast, the elevation of antibody level may merely reflect the fact that the organism was once involved in the pathogenesis and progression of periodontitis (7) or may indicate that the destruction of periodontal tissue is rapid and severe (5) . In the present study, the presence of specific IgG antibodies against the fimbria antigen of A. actinomycetemcomitans was observed. Although no statistically significant difference was found, the patients without cultivable A. actinomycetemcomitans showed higher serum IgG titers against the fimbria antigen than did those with cultivable A. actinomycetemcomitans. This leads us to the hypothesis that the specific IgG titer to the fimbria antigen elicited by initial contact with A. actinomycetemcomitans played a role in clearing the organisms from the periodontal pockets of these patients. However, the patients harboring A. actinomycetemcomitans in their periodontal pockets also had significantly higher serum IgG titers against the fimbria antigen than did periodontally healthy individuals, and the frequencies of patients who showed elevated levels of antibody against the fimbria antigen were greater than those without A. actinomycetemcomitans.
Periodontally healthy individuals had significantly higher avidities for the fimbria antigens than did the patient group. Chen et al. (2) that the difference between protective and nonprotective antibodies is the avidity that the antibody demonstrates for the epitope recognized on the surface of the bacteria. Furthermore, for patients without cultivable A. actinomycetemcomitans, a significantly positive correlation was observed between the titers and avidities, whereas the correlation was negative for other groups. In other words, for periodontally healthy individuals or patients harboring A. actinomycetemcomitans, a higher titer is not accompanied by a higher avidity. Thus, the patients not harboringA. actinomycetemcomitans in the present study appeared to be capable of mounting a biologically significant humoral immune response to A. actinomycetemcomitans fimbriae.
In summary, the presence of specific and biologically functional serum IgG antibodies to the fimbria antigen of A. actinomycetemcomitans was confirmed in patients with adult periodontitis. The elicited antibodies against the fimbria antigen may afford protection against continued infection by A. actinomycetemcomitans.
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